Experimental infection with bovine ephemeral fever virus and analysis of its antibody response cattle.

Bovine ephemeral fever (BEF) is an arthropod-borne viral disease that occurs throughout mainland China. LS11 obtained in the 2011 BEF epidemic was a wild strain, and its virulence and antibody response have never been studied in China. Therefore, the issues were investigated in this work. Experimental cattle were intravenously infected with different doses of BEF virus, and some non-infected cattle were simultaneously monitored. Blood and serum samples were collected from all animals over the course of our study. Infected cattle were challenged for a second time with BEF virus to determine protective period of the antibodies. BEF virus was detected in blood samples from infected cattle, but not in monitored cattle. The neutralizing antibodies (nAbs) against BEFV were easier to be detected and persisted for longer periods in cattle infected with higher doses of BEFV than in those infected with lower doses. When the titer of nAbs was equal to 5 or 6, re-infected cattle still could mount a challenge against BEFV. However, after 3 or 6months, when nAbs were no longer apparent, re-infected cattle displayed typical symptoms of BEF. Our findings indicated that vaccination should be performed once the titer of nAb decreased to 5 or 6.

Bovine ephemeral fever in Taiwan.

Bovine ephemeral fever (BEF) is a vector-borne disease of cattle, spanning tropical and subtropical zones of Asia, Australia, and Africa, caused by Ephemerovirus of the Rhabdoviridae. Taiwan has had 3 BEF epizootics, occurring in 1989, 1996, and 1999, since the vaccination regimen was initiated in 1984, given once a year in the spring with a single-dose formaldehyde-inactivated vaccine using the 1983 isolate as the seed virus. This study evaluated the 1999 population immunity against BEF virus in Taiwanese dairy cows with a neutralization test and whether the recent BEF virus isolates have mutated significantly from the vaccine virus. In March 1999, before vaccination, 94% of the animals studied were already seropositive, suggestive of an endemic or persistent infection from the previous year. By June 1999, when 51% of herds had been vaccinated, the antibody level rose, and by September 1999, the serum-neutralizing antibody (SNA) level fell to a minimum, preceding the outbreak of BEF in October 1999, during which the antibody levels of vaccinated cows continued to decline while those of unvaccinated cows rose sharply. The results suggest that, in 1999, vaccine-induced immunity was partially protective against BEE Because the current single-dose vaccination regimen resulted in minimal population immunity by September, a booster vaccination given in late summer may be advisable for future disease control. Analysis of the glycoprotein gene of Taiwanese isolates between 1983 and 1999 showed a 97.4-99.6% homology, with an alteration of 4 amino acids in antigenic sites G1, G3b, and G3c. Phylogenetic analysis of Taiwanese isolates revealed at least 2 distinct clusters: the 1983-1989 isolates and the 1996-1999 isolates. Both were distinct from 2 Japanese strains and the Australian BB7721 strain. Thus, at least 2 distinct BEF viruses, which had diverged before 1983, existed in Taiwanese dairy cows.

Epidemiological investigations of outbreaks of bovine ephemeral fever in Israel.

In two epidemics of bovine ephemeral fever (BEF) in Israel, one in 1990 and one in 1999, the virus was probably carried by vectors transported by air currents across the Rift Valley and through the Red Sea trough. The disease broke out under optimal ecological conditions among vulnerable cattle populations and spread rapidly; it developed in the spring and summer and ended soon after the daily average ambient temperature fell below 16 degrees C in late autumn. The proportion of herds affected reached 78.4 and 97.7 per cent in 1990 and 1999, respectively. The highest rates of incidence, morbidity and mortality were recorded in dairy cattle herds in the Jordan Valley, the initial focus of the outbreaks, with a morbidity of 20 and 38.6 per cent in 1990 and 1999, respectively, and mortality among the affected animals of 2 and 8.6 per cent in 1990 and 1999, respectively. In 1991, the disease recurred sporadically in the central and southern regions of Israel in only three herds, but in 2000 the disease returned on an epidemic scale, and 85 per cent of herds were affected, with morbidity and mortality rates of 4-3 and 0-3 per cent, respectively. In the 1999 epidemic, the morbidity rate decreased from 38-6 per cent on average in the Jordan Valley to 12.8 per cent in the inner valleys and 5.3 per cent on the Mediterranean coastal plain, but the mortality rate increased from 8-6 per cent in the Jordan Valley to 14-3 per cent in the inner valleys, and to 28 per cent on the Mediterranean coastal plain, where the outbreak declined. An average of 2-7 per cent of the animals experienced a second attack of the disease two to six weeks later. The epidemic in 2000 was milder and shorter than that in 1999. All the cattle affected in both outbreaks were more than three months old. The vector(s) is not known for certain but the available evidence indicates that mosquitoes, and not Culicoides species, are the natural vectors of BEF virus in Israel.

Effective vaccination of cattle using the virion G protein of bovine ephemeral fever virus as an antigen.

In a series of experiments, the envelope glycoprotein (G protein) of bovine ephemeral fever virus (BEFV) induced immunity against challenge with virulent virus. Protection correlated with the level of specific serum antibodies to G protein measured by a blocking ELISA test and with the level of neutralizing antibody. The optimum vaccination regimen consisted of two injections given 21 days apart at a dose rate of 0.32 microgram per cow of purified G protein emulsified in the adjuvant Quil A. This schedule conferred immunity for the duration of the preliminary experiment (46 days). Immunity to severe disease, but not to infection, remained for at least 12 months after vaccination, although BEFV could not be reisolated from vaccinated cattle following challenge. Unvaccinated cattle used as controls exhibited typical signs of clinical ephemeral fever and BEFV was recovered from all control animals following challenge.